Belinda Bennett on Globalization and the Future of Health Law: Introduced by I. Glenn Cohen

International Legal Studies at HLS, October 22, 2013

Globalization and the Future of Health Law: Harmonization or Diversity? A talk by Belinda Bennett, Professor of Health and Medical Law, University of Sydney Introduction by I. Glenn Cohen   Tuesday,…

Read More

Obamacare becomes test of faith for employer over birth control

The Washington Times, October 14, 2013
Tom Howell, Jr. quoting Holly Fernandez Lynch

[...]  The battle lines are drawn, but analysts of all stripes agree the case is on the fast-track for the highest court in the land. “I think it’s a foregone conclusion the Supreme Court will take this up,” said Holly…

Read More

Now Available: Globalization of Healthcare

Oxford University Press, 2013
I. Glenn Cohen, ed.

The edited volume stemming from the Petrie-Flom Center's 2011 Annual Conference, The Globalization of Health Care: Legal and Ethical Issues, I.…

Read More

Apply for 2014 Petrie-Flom Academic Fellowship

PURPOSE: The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics is an interdisciplinary research program at Harvard Law School dedicated to scholarly research at the intersection of law and health policy, including issues of health care financing and market regulation, biomedical…

Read More

Petrie-Flom Student Fellow Jeremy Kreisberg featured in: "The Most Impressive Students At Harvard Law School"

Business Insider, October 7, 2013
Melissa Stanger

Jeremy Kreisberg has retinitis pigmentosa, a degenerative eye condition, but it hasn't stopped him from following his dreams and becoming involved in the Harvard Law community. [...]   

Read More

Video Now Available: Symposium Honoring Founding Faculty Director Einer Elhauge

Tulsa Law Review, October 4, 2013

On Friday, October 4, the Tulsa Law Review hosted a symposium titled "Health…

Read More

At Harvard Law School, a panel ponders the effects of the Court’s ruling on gene patenting

Spotlight at Harvard Law School, October 3, 2013
Dick Dahl

Experts in the fields of law, science, and technology gathered at Harvard Law School Sept. 23 for a panel discussion, co-sponsored by the Broad Institute of MIT and HLS' Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, examining the impact of the U.S. Supreme…

Read More

Day 2 of Obamacare: After rocky start, Obama admin. launches awareness campaign

The Washington Post, October 2, 2013
Tom Howell, Jr., quoting I. Glenn Cohen

"But service disruptions, should they continue, could spell trouble as the calendar nears a Dec. 15 cutoff for consumers who want to be insured by January — the month all Americans must have some form of health coverage or face fines under the health care law’s individual mandate. …

Read More

As More Americans Have Surgeries Overseas, US Companies Consider ‘Medical Tourism’: a Health Care Option

Nightline: Late Evening News - ABC News, September 30, 2013
Byron Pitts and Nikki Batiste, featuring I. Glenn Cohen

Petrie-Flom Center Faculty Co-Director I. Glenn Cohen discusses safety issues and medical tourism.

Read More

American Companies Sending Workers on Surgery Vacations

ABC World News, September 30, 2013
Byron Pitts, featuring I. Glenn Cohen

Petrie-Flom Center Faculty Co-Director I. Glenn Cohen discusses safety issues and medical tourism.

Read More

Praise for “Making Do in Making Drugs” by W. Nicholson Price II

Written Description: Patent & IP Blog, Reviewing Recent Scholarship on Patent Law, IP Theory, and Innovation, September 28, 2013
Camilla Alexandra Hrdy

"'M&M chocolate candies are made with a precision far beyond the capabilities of many drug manufacturers.' This is the intriguing opening to a thorough critique of innovation in pharmaceutical manufacturing by Nicholson…

Read More

Government: When push comes to nudge: How a choice offered can affect what we choose.

Los Angeles Times, September 29, 2013
Michelle N. Meyer and Christopher Chabris

Co-authored by Petrie-Flom Academic Fellow Alumna Michelle N. Meyer:  News came last month that the Obama administration, following the lead of British Prime Minister David Cameron and…

Read More

HLS Panel Discusses Gene Patents

The Harvard Crimson, September 24, 2013
Andrew Ma

"Panelists at Monday’s discussion about the recent Supreme Court decision against gene patenting agreed that although patenting might provide incentives to aspiring innovators, it often hinders scientific progress, especially when it concerns the DNA sequences that are found within human bodies. …

Read More

Stretching Cuccinelli’s Record, September 19, 2013
Robert Farley and Eugene Kiely, quoting I. Glenn Cohen

[...] Harvard Law School Professor I. Glenn Cohen, co-director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, told us in an email that Cuccinelli’s support for “personhood”…

Read More

Perceptions of Efficacy, Morality, and Politics of Potential Cadaveric Organ Transplantation Reforms

Law and Contemporary Problems, Forthcoming
Christopher T. Robertson, David V. Yokum, and Megan S. Wright

We sought to explore the political feasibility of potential policy reforms to address the shortage of cadaveric organs for transplantation in America. We recruited 730 human subjects from an online population and assigned them to writing tasks that experimentally manipulated the salience of moral…

Read More

HLS Event Opens Dialogue on Role of Race in Healthcare

The Harvard Crimson, Sept. 18, 2013
Andrew Ma

Harvard Crimson coverage of the Petrie-Flom Center's September 17, 2013, panel discussion, "Patient Discrimination against Medical Personnel," featuring Kimani Paul-Emile of Fordham Law School discussing her article…

Read More

Anonymity, the Production of Goods, and Institutional Design

Fordham Law Review, Forthcoming
Jeffrey Skopek

Abstract: In this article, I demonstrate that anonymity has been misconceived as an aspect of privacy, and that understanding this mistake reveals a powerful and underutilized set of legal tools for facilitating and controlling the production of information and other social…

Read More

Making Do in Making Drugs: Innovation Policy and Pharmaceutical Manufacturing

Boston College Law Review, forthcoming
W. Nicholson Price II

Abstract:   Drug recalls, contamination events, and shortages are on the rise, but drug companies still rely on decades-old manufacturing plants and processes. Contrary to widespread perceptions, drug manufacturing is typically expensive, inefficient, and non-innovative.…

Read More

Poll finds more share negative view of Obamacare: Express uncertainty about law two weeks before phase kicks in

The Washington Times, Sept. 16, 2013
Tom Howell Jr.

"From its inception, the administration has had difficulty explaining the provisions of the [law]," said I. Glenn Cohen, a health-policy specialist at Harvard Law School. "I do think, though, if it stays the course, that…

Read More

When Truth Cannot Be Presumed: The Regulation of Drug Promotion under an Expanding First Amendment

Boston University Law Review, 2014
Christopher T. Robertson

Abstract:       The Food, Drug, and Cosmetic Act (“FDCA”) requires that, prior to marketing a drug, the manufacturer must prove that it is safe and effective for the manufacturer’s intended uses, as shown on the proposed label.…

Read More